Urgent.News

What's breaking now, across thousands of outlets.

More in Finance & Markets

Invesco’s RSPH or iShares’ IBB: Which Healthcare ETF Is the Better Long-Term Buy?

RSPH offers broader healthcare exposure with lower volatility and higher dividend yield, while IBB provides concentrated biotech focus with stronger recent returns.

  • Invesco's RSPH offers diversified, equal-weighted healthcare strategy
  • IBB provides focused, market-cap-weighted exposure to biotechnology
  • RSPH has lower expense ratio (0.4%) and higher yield (0.6%) vs IBB's (0.44%) and 0.2%

More from Monday 26 October →